Cargando…
MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells
OBJECTIVE: Cisplatin, the most common chemotherapeutic drug for the treatment of advanced stage cervical cancers has limitations in terms of drugs resistance observed in patients partly due to functional DNA damage repair (DDR) processes in the cell. Mediator of DNA damage checkpoint 1 (MDC1) is an...
Autores principales: | Singh, Neeru, Bhakuni, Rashmi, Chhabria, Dimple, Kirubakaran, Sivapriya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066845/ https://www.ncbi.nlm.nih.gov/pubmed/32160908 http://dx.doi.org/10.1186/s13104-020-04996-5 |
Ejemplares similares
-
Design, Synthesis, and Docking Studies of New Torin2 Analogs as Potential ATR/mTOR Kinase Inhibitors †
por: Shaik, Althaf, et al.
Publicado: (2018) -
Benzothiazole and Chromone Derivatives as Potential ATR Kinase Inhibitors and Anticancer Agents
por: Frasinyuk, Mykhaylo, et al.
Publicado: (2022) -
Depletion of NFBD1/MDC1 Induces Apoptosis in Nasopharyngeal Carcinoma Cells Through the p53–ROS–Mitochondrial Pathway
por: Wang, Zhihai, et al.
Publicado: (2017) -
Exploring SPK98 for the Selective Sensitization of
ATM- or P53-Deficient Cancer Cells
por: Priya, Bhanu, et al.
Publicado: (2023) -
Bixin and fucoxanthin sensitize human lung cancer and cervical cancer cell to cisplatin in vitro
por: Nurcahyanti, Agustina Dwi Retno, et al.
Publicado: (2021)